{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:09:04Z","timestamp":1778170144619,"version":"3.51.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.01018","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T08:44:42Z","timestamp":1599727482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Differences in Thyroid Function and Autoantibodies in the Development of Guillain\u2013Barr\u00e9 Syndrome vs. Chronic Inflammatory Demyelinating Polyradiculoneuropathy"],"prefix":"10.3389","volume":"11","author":[{"given":"Yu","family":"Tu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanwen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"CD001446","DOI":"10.1002\/14651858.CD001446.pub5","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"10","author":"Hughes","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1085-9489.2006.00063.x","article-title":"Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy","volume":"11","author":"Comi","year":"2006","journal-title":"J Peripher Nerv Syst"},{"key":"B3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European federation of neurological societies\/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the european federation of neurological societies and the peripheral nerve society - first revision","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1089\/thy.2012.0205","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association","volume":"22","author":"Garber","year":"2012","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/mus.21138","article-title":"Early neurophysiological evolution of chronic inflammatory demyelinating polyneuropathy in a patient with Hashimoto's thyroiditis","volume":"38","author":"Bairactaris","year":"2008","journal-title":"Muscle Nerve"},{"key":"B6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/qjmed\/hcw007","article-title":"Guillain\u2013Barre syndrome and hashimoto's thyroiditis","volume":"109","author":"Toudou Daouda","year":"2016","journal-title":"QJM"},{"key":"B7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/00207454.2016.1278541","article-title":"Thyroid hormone level is associated with the frequency and severity of Guillain-Barr\u00e9 syndrome","volume":"127","author":"Huang","year":"2017","journal-title":"Int J Neurosci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Guillain-Barr\u00e9 and miller fisher syndromes\u2013new diagnostic classification","volume":"10","author":"Wakerley","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/mus.25266","article-title":"Anti-ganglioside antibodies in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients","volume":"55","author":"Fan","year":"2017","journal-title":"Muscle Nerve"},{"key":"B11","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1038\/s41598-017-14853-4","article-title":"Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"7","author":"Querol","year":"2017","journal-title":"Sci Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.autrev.2011.08.011","article-title":"The role of T cell apoptosis in nervous system autoimmunity","volume":"12","author":"Comi","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1046\/j.1365-2249.2003.02221.x","article-title":"Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diseases","volume":"133","author":"Bona","year":"2003","journal-title":"Clin Exp Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1529-8027.2009.00219.x","article-title":"Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP","volume":"14","author":"Comi","year":"2009","journal-title":"J Peripher Nerv Syst"},{"key":"B15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1684\/ecn.2019.0436","article-title":"IL-8 as a potential biomarker in Guillain-Barre syndrome","volume":"30","author":"Breville","year":"2019","journal-title":"Eur Cytokine Netw"},{"key":"B16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000363162","article-title":"Clinical aspects of hashimoto's thyroiditis","volume":"26","author":"Radetti","year":"2014","journal-title":"Endocr Dev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.psyneuen.2009.03.011","article-title":"Increased prevalence of antibodies to central nervous system tissue and gangliosides in hashimoto's thyroiditis compared to other thyroid illnesses","volume":"34","author":"M\u00fcssig","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"B18","first-page":"596","article-title":"Role of related cytokines in the pathogenesis of Guillain-Barre syndrome","volume":"38","author":"Yang","year":"2015","journal-title":"Int J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2014.12.017","article-title":"Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy","volume":"279","author":"Beppu","year":"2015","journal-title":"J Neuroimmunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/ene.12971","article-title":"NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy","volume":"23","author":"Marrali","year":"2016","journal-title":"Eur J Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/01616412.2019.1573955","article-title":"Dynamic thiol-disulphide homeostasis in patients with Guillain-Barre Syndrome","volume":"41","author":"G\u00fcm\u00fc\u015fyayla","year":"2019","journal-title":"Neurol Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/meta.2002.34717","article-title":"Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis","volume":"51","author":"Kokkotou","year":"2002","journal-title":"Metabolism"},{"key":"B23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2265.2005.02324.x","article-title":"Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in hashimoto's thyroiditis","volume":"63","author":"Karanikas","year":"2005","journal-title":"Clin Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10072-011-0579-3","article-title":"Temporal coincidence of myasthenia gravis and Guillain Barr\u00e9 syndrome associated with hashimoto thyroiditis","volume":"32","author":"Wang","year":"2011","journal-title":"Neurol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2174\/156652409789839116","article-title":"Sexual dimorphism in autoimmune disease","volume":"9","author":"McCombe","year":"2009","journal-title":"Curr Mol Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.01018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T14:39:50Z","timestamp":1723559990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.01018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":25,"alternative-id":["10.3389\/fneur.2020.01018"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.01018","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"article-number":"1018"}}